222 related articles for article (PubMed ID: 25569743)
1. Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
Khare V; Dammann K; Asboth M; Krnjic A; Jambrich M; Gasche C
Inflamm Bowel Dis; 2015 Feb; 21(2):287-96. PubMed ID: 25569743
[TBL] [Abstract][Full Text] [Related]
2. A Novel PAK1-Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation.
Frick A; Khare V; Jimenez K; Dammann K; Lang M; Krnjic A; Gmainer C; Baumgartner M; Mesteri I; Gasche C
Cell Mol Gastroenterol Hepatol; 2021; 11(3):892-907.e1. PubMed ID: 33189893
[TBL] [Abstract][Full Text] [Related]
3. PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation.
Dammann K; Khare V; Lang M; Claudel T; Harpain F; Granofszky N; Evstatiev R; Williams JM; Pritchard DM; Watson A; Gasche C
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2349-60. PubMed ID: 26036343
[TBL] [Abstract][Full Text] [Related]
4. Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1.
Khare V; Lyakhovich A; Dammann K; Lang M; Borgmann M; Tichy B; Pospisilova S; Luciani G; Campregher C; Evstatiev R; Pflueger M; Hundsberger H; Gasche C
Biochem Pharmacol; 2013 Jan; 85(2):234-44. PubMed ID: 23146664
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
8. Upregulated claudin-1 expression promotes colitis-associated cancer by promoting β-catenin phosphorylation and activation in Notch/p-AKT-dependent manner.
Gowrikumar S; Ahmad R; Uppada SB; Washington MK; Shi C; Singh AB; Dhawan P
Oncogene; 2019 Jun; 38(26):5321-5337. PubMed ID: 30971761
[TBL] [Abstract][Full Text] [Related]
9. p-21-Activated kinase 1 mediates gastrin-stimulated proliferation in the colorectal mucosa via multiple signaling pathways.
Huynh N; Yim M; Chernoff J; Shulkes A; Baldwin GS; He H
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G561-7. PubMed ID: 23306081
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
Piazzi G; D'Argenio G; Prossomariti A; Lembo V; Mazzone G; Candela M; Biagi E; Brigidi P; Vitaglione P; Fogliano V; D'Angelo L; Fazio C; Munarini A; Belluzzi A; Ceccarelli C; Chieco P; Balbi T; Loadman PM; Hull MA; Romano M; Bazzoli F; Ricciardiello L
Int J Cancer; 2014 Nov; 135(9):2004-13. PubMed ID: 24676631
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.
Lee G; Goretsky T; Managlia E; Dirisina R; Singh AP; Brown JB; May R; Yang GY; Ragheb JW; Evers BM; Weber CR; Turner JR; He XC; Katzman RB; Li L; Barrett TA
Gastroenterology; 2010 Sep; 139(3):869-81, 881.e1-9. PubMed ID: 20580720
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the Intestinal Anti-inflammatory and Antitumor Potential of Artepillin C.
da Silva LM
Curr Mol Pharmacol; 2024; 17(1):e260423216212. PubMed ID: 37185322
[TBL] [Abstract][Full Text] [Related]
13. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
Deng L; Zhou JF; Sellers RS; Li JF; Nguyen AV; Wang Y; Orlofsky A; Liu Q; Hume DA; Pollard JW; Augenlicht L; Lin EY
Am J Pathol; 2010 Feb; 176(2):952-67. PubMed ID: 20042677
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-β protects against colitis-associated neoplasia in mice.
Saleiro D; Murillo G; Benya RV; Bissonnette M; Hart J; Mehta RG
Int J Cancer; 2012 Dec; 131(11):2553-61. PubMed ID: 22488198
[TBL] [Abstract][Full Text] [Related]
15. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.
Managlia E; Katzman RB; Brown JB; Barrett TA
Inflamm Bowel Dis; 2013 Sep; 19(10):2051-60. PubMed ID: 23867870
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
19. PAK1 promotes intestinal tumor initiation.
Dammann K; Khare V; Harpain F; Lang M; Kurtovic A; Mesteri I; Evstatiev R; Gasche C
Cancer Prev Res (Phila); 2015 Nov; 8(11):1093-101. PubMed ID: 26304465
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer.
Zou F; Mao R; Yang L; Lin S; Lei K; Zheng Y; Ding Y; Zhang P; Cai G; Liang X; Liu J
FEBS J; 2016 Apr; 283(8):1438-52. PubMed ID: 26859226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
